Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf Adherence in Kidney Transplant
NCT02805842Phase 3Unknown
- Sponsor
- Rabin Medical Center
- Start
- Aug 2016
- Primary completion
- Aug 2018
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus in kidney transplant rejection (2 arms), sponsored by Rabin Medical Center. Primary endpoint: Morisky Medical Adherence Assessment questionnaire at 2 years. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02805842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805842.